(Q35870842)

10 August 2017

1 reference

title

Sputum tests in the diagnosis and monitoring of asthma (English)

1 reference

10 August 2017

0 references

1 reference

Chang Keun Kim

1

1 reference

10 August 2017

John B Hagan

series ordinal

2

1 reference

10 August 2017

language of work or name

1 reference

1 August 2004

1 reference

Annals of Allergy, Asthma & Immunology

10 August 2017

published in

1 reference

10 August 2017

volume

93

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

112-22; quiz 122-4, 184

1 reference

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Exhaled markers of pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

The health economics of asthma and rhinitis. I. Assessing the economic impact

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Using Global Initiative for Asthma guidelines to assess asthma severity in populations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

1 reference

7 January 2021

Factors associated with persistent airflow limitation in severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

The relationship between airways inflammation and asthma severity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Eosinophilic inflammation in sputum of poorly controlled asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Significant variability in response to inhaled corticosteroids for persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Airway remodeling in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Eosinophilic bronchitis: clinical manifestations and implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Potential masking effects of salmeterol on airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Induced sputum cell counts in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Inhalation provocation tests using nonisotonic aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Validity and safety of sputum induction by inhaled uridine 5'-triphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Comparative efficacy of salbutamol, ipratropium, and cromoglycate in the prevention of bronchospasm induced by exercise and hyperosmolar challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Safety of one method of sputum induction in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Induced sputum, bronchoalveolar lavage and blood from mild asthmatics: inflammatory cells, lymphocyte subsets and soluble markers compared

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Induced sputum cellularity. Reference values and distribution in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Comparison of Two Methods of Processing Induced Sputum: Selected versus Entire Sputum

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Comparison of two methods of processing induced sputum: selected versus entire sputum

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Sputum processing for evaluation of inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Optimization of sputum-processing methods for the measurement of interleukin-5: effects of protease inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Induced sputum: time from expectoration to processing.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

A comparison of the validity of different diagnostic tests in adults with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Differential cell counts in sputum in respiratory epidemiology: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levels and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Airway inflammation is present during clinical remission of atopic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Outgrown asthma does not mean no airways inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Exacerbations of asthma without sputum eosinophilia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Non-eosinophilic asthma: importance and possible mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Chronic cough: eosinophilic bronchitis without asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Eosinophilic inflammation in cough variant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Eosinophilic airway inflammation as an underlying mechanism of undiagnosed prolonged cough in primary healthcare patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

The Relationship between Airway Responsiveness to Histamine and Pulmonary Function Level in a Random Population Sample

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Inhaled corticosteroids and chronic obstructive pulmonary disease: are we barking up the wrong tracheobronchial tree?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

New concepts in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Diagnosing occupational asthma: use of induced sputum

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Recent advances in occupational asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Occupational eosinophilic bronchitis without asthma: an unknown occupational airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Sputum eosinophilia after asthmatic responses induced by isocyanates in sensitized subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961462-7

7 January 2021

10.1016/S1081-1206(10)61462-7

Identifiers

DOI

1 reference

10 August 2017

1 reference